Biocon included in S&P Global Sustainability Yearbook 2024, ET HealthWorld

[ad_1]

Bengaluru: Biocon Limited today announced its inclusion in S&P’s Sustainability Yearbook 2024 for the second consecutive year, based on the S&P Global Corporate Sustainability Assessment (CSA) of Biocon and Biocon Biologics Limited for 2023.

Biocon’s S&P Global ESG score was 63 versus 52 previously, placing it among the Top 10 global biotechnology companies from within the 300 companies that were assessed.

Kiran Mazumdar Shaw, Chairperson, Biocon & Biocon Biologics, said: “We are pleased to be recognised by S&P Global for our robust sustainable business practices. As a responsible corporate citizen, we are implementing a comprehensive ESG strategy across Biocon Group in line with our philosophy of Unconditional Equity. We are continuously striving to enable Patient Equity, People Equity, Environmental Equity, Stakeholder Equity and Social Equity.”

The S&P Global CSA, a leading corporate sustainability database, enables companies to directly report key sustainability metrics and benchmark their sustainability performance on a wide range of industry-specific economic, environmental, and social criteria. The CSA score shows how a company compares with its peers and members of the prestigious Dow Jones Sustainability Indices (DJSI).
Based on its score, Biocon (including Biocon Biologics) has also been named among global sustainability leaders for the third consecutive year in the Dow Jones Sustainability Emerging Markets Index.

  • Published On Feb 20, 2024 at 01:19 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles


Scan to download App


[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *